EP 0728010 A4 19971001 - METHOD FOR TREATING HEPATITIS B CARRIERS WITH MINIMAL DISEASE
Title (en)
METHOD FOR TREATING HEPATITIS B CARRIERS WITH MINIMAL DISEASE
Title (de)
VERFAHREN ZUR BEHANDLUNG VON HEPATITIS B TRAGERN MIT GERINGFUEGIGER ERKRANKUNG
Title (fr)
METHODE DE TRAITEMENT DE PORTEURS DE L'HEPATITE B PRESENTANT UN ETAT PATHOLOGIQUE MINIME
Publication
Application
Priority
- US 9310343 W 19931028
- US 83346892 A 19920206
Abstract (en)
[origin: WO9511688A1] Thymosin alpha -1, or biologically active fragments or analogs of thymosin alpha -1, are administered for treatment of minimal disease hepatitis B infection.
IPC 1-7
IPC 8 full level
A61K 35/55 (2006.01); A61K 38/00 (2006.01); A61K 38/08 (2006.01); A61K 38/22 (2006.01)
IPC 8 main group level
A61K (2006.01)
CPC (source: EP)
A61K 38/2292 (2013.01)
Citation (search report)
- [A] WO 9305806 A1 19930401 - ALPHA 1 BIOMEDICALS INC [US], et al
- [E] US 5308833 A 19940503 - SCHARSCHMIDT BRUCE F [US], et al
- [A] BIOLOGICAL ABSTRACTS, vol. 92, no. 11, 1991, Philadelphia, PA, US; abstract no. 121545, M.G. MUTCHNICK ET AL.: "THYMOSIN TREATMENT OF CHRONIC HEPATITIS B: A PLACEBO-CONTROLLED PILOT TRIAL." page 229; XP002036518 & HEPATOLOGY, vol. 14, no. 3, 1991, pages 409 - 415
- See references of WO 9511688A1
Designated contracting state (EPC)
AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
WO 9511688 A1 19950504; EP 0728010 A1 19960828; EP 0728010 A4 19971001; NO 961685 D0 19960426; NO 961685 L 19960426; SG 64892 A1 19990525; TW 249755 B 19950621
DOCDB simple family (application)
US 9310343 W 19931028; EP 93925097 A 19931028; NO 961685 A 19960426; SG 1996005575 A 19931028; TW 82109202 A 19931102